Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1635307

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1635307

Asia Pacific Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile based Applications, Sensors, and Other Type), By Clinical Practice, By End Use, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 97 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Asia Pacific Psychiatric Digital Biomarkers Market would witness market growth of 25.3% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Psychiatric Digital Biomarkers Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $162.9 million by 2031. The Japan market is experiencing a CAGR of 24.5% during (2024 - 2031). Additionally, The India market would exhibit a CAGR of 26.1% during (2024 - 2031).

Machine learning enhances these applications by enabling predictive analytics, such as forecasting relapse risks in chronic conditions like bipolar disorder. For example, irregular sleep patterns, reduced physical activity, and heart rate variability changes could signal an impending manic or depressive episode, prompting timely clinical intervention. ML models continuously refine their accuracy by learning from new data, making them highly effective for personalized care.2 para overviews

India also faces significant mental health challenges, with epidemiological studies reporting prevalence rates ranging from 9.5 to 370 per 1,000 people. Common disorders include depression, anxiety, bipolar disorder, schizophrenia, and substance use disorders. The mental health burden in India is immense, with 2,443 disability-adjusted life years (DALYs) per 10,000 population and an age-adjusted suicide rate of 21.1 per 100,000 population. Additionally, the economic cost of mental health issues in India from 2012 to 2030 is estimated to be USD 1.03 trillion, emphasizing the urgent need for effective interventions and support systems. Consequently, digital biomarkers can be instrumental in the improvement of regional outcomes and the bridging of care disparities by facilitating the early detection and monitoring of mental health conditions.

Based on Type, the market is segmented into Wearable, Mobile based Applications, Sensors, and Other Type. Based on Clinical Practice, the market is segmented into Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive and Prognostic Psychiatric Digital Biomarkers, and Other Clinical Practice. Based on End Use, the market is segmented into Healthcare Companies, Healthcare Providers, Payers, and Other End Use. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • Canary Speech, Inc
  • Sonde Health, Inc. (Puretech Health Plc)
  • Koneksa Health Inc.
  • Empatica Inc.
  • VivoSense, Inc.
  • IXICO Plc
  • Neurotrack Technologies, Inc.
  • Winterlight Labs
  • Aural Analytics, Inc. (Linus Health)

Asia Pacific Psychiatric Digital Biomarkers Market Report Segmentation

By Type

  • Wearable
  • Mobile based Applications
  • Sensors
  • Other Type

By Clinical Practice

  • Diagnostic Psychiatric Digital Biomarkers
  • Monitoring Psychiatric Digital Biomarkers
  • Predictive and Prognostic Psychiatric Digital Biomarkers
  • Other Clinical Practice

By End Use

  • Healthcare Companies
  • Healthcare Providers
  • Payers
  • Other End Use

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Psychiatric Digital Biomarkers Market, by Type
    • 1.4.2 Asia Pacific Psychiatric Digital Biomarkers Market, by Clinical Practice
    • 1.4.3 Asia Pacific Psychiatric Digital Biomarkers Market, by End Use
    • 1.4.4 Asia Pacific Psychiatric Digital Biomarkers Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Psychiatric Digital Biomarkers Market by Type

  • 4.1 Asia Pacific Wearable Market by Country
  • 4.2 Asia Pacific Mobile based Applications Market by Country
  • 4.3 Asia Pacific Sensors Market by Country
  • 4.4 Asia Pacific Other Type Market by Country

Chapter 5. Asia Pacific Psychiatric Digital Biomarkers Market by Clinical Practice

  • 5.1 Asia Pacific Diagnostic Psychiatric Digital Biomarkers Market by Country
  • 5.2 Asia Pacific Monitoring Psychiatric Digital Biomarkers Market by Country
  • 5.3 Asia Pacific Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country
  • 5.4 Asia Pacific Other Clinical Practice Market by Country

Chapter 6. Asia Pacific Psychiatric Digital Biomarkers Market by End Use

  • 6.1 Asia Pacific Healthcare Companies Market by Country
  • 6.2 Asia Pacific Healthcare Providers Market by Country
  • 6.3 Asia Pacific Payers Market by Country
  • 6.4 Asia Pacific Other End Use Market by Country

Chapter 7. Asia Pacific Psychiatric Digital Biomarkers Market by Country

  • 7.1 China Psychiatric Digital Biomarkers Market
    • 7.1.1 China Psychiatric Digital Biomarkers Market by Type
    • 7.1.2 China Psychiatric Digital Biomarkers Market by Clinical Practice
    • 7.1.3 China Psychiatric Digital Biomarkers Market by End Use
  • 7.2 Japan Psychiatric Digital Biomarkers Market
    • 7.2.1 Japan Psychiatric Digital Biomarkers Market by Type
    • 7.2.2 Japan Psychiatric Digital Biomarkers Market by Clinical Practice
    • 7.2.3 Japan Psychiatric Digital Biomarkers Market by End Use
  • 7.3 India Psychiatric Digital Biomarkers Market
    • 7.3.1 India Psychiatric Digital Biomarkers Market by Type
    • 7.3.2 India Psychiatric Digital Biomarkers Market by Clinical Practice
    • 7.3.3 India Psychiatric Digital Biomarkers Market by End Use
  • 7.4 South Korea Psychiatric Digital Biomarkers Market
    • 7.4.1 South Korea Psychiatric Digital Biomarkers Market by Type
    • 7.4.2 South Korea Psychiatric Digital Biomarkers Market by Clinical Practice
    • 7.4.3 South Korea Psychiatric Digital Biomarkers Market by End Use
  • 7.5 Singapore Psychiatric Digital Biomarkers Market
    • 7.5.1 Singapore Psychiatric Digital Biomarkers Market by Type
    • 7.5.2 Singapore Psychiatric Digital Biomarkers Market by Clinical Practice
    • 7.5.3 Singapore Psychiatric Digital Biomarkers Market by End Use
  • 7.6 Malaysia Psychiatric Digital Biomarkers Market
    • 7.6.1 Malaysia Psychiatric Digital Biomarkers Market by Type
    • 7.6.2 Malaysia Psychiatric Digital Biomarkers Market by Clinical Practice
    • 7.6.3 Malaysia Psychiatric Digital Biomarkers Market by End Use
  • 7.7 Rest of Asia Pacific Psychiatric Digital Biomarkers Market
    • 7.7.1 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by Type
    • 7.7.2 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by Clinical Practice
    • 7.7.3 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by End Use

Chapter 8. Company Profiles

  • 8.1 Canary Speech, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 SWOT Analysis
  • 8.2 Sonde Health, Inc. (Puretech Health Plc)
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Research & Development Expenses
    • 8.2.4 Recent strategies and developments:
      • 8.2.4.1 Partnerships, Collaborations, and Agreements:
      • 8.2.4.2 Product Launches and Product Expansions:
    • 8.2.5 SWOT Analysis
  • 8.3 Koneksa Health Inc.
    • 8.3.1 Company Overview
  • 8.4 Empatica Inc.
    • 8.4.1 Company Overview
  • 8.5 VivoSense, Inc.
    • 8.5.1 Company Overview
  • 8.6 IXICO plc
    • 8.6.1 Company Overview
  • 8.7 Neurotrack Technologies, Inc.
    • 8.7.1 Company Overview
  • 8.8 WinterLight Labs
    • 8.8.1 Company Overview
  • 8.9 Aural Analytics, Inc. (Linus Health)
    • 8.9.1 Company Overview

LIST OF TABLES

  • TABLE 1 Asia Pacific Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
  • TABLE 2 Asia Pacific Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
  • TABLE 3 Asia Pacific Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
  • TABLE 4 Asia Pacific Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
  • TABLE 5 Asia Pacific Wearable Market by Country, 2020 - 2023, USD Million
  • TABLE 6 Asia Pacific Wearable Market by Country, 2024 - 2031, USD Million
  • TABLE 7 Asia Pacific Mobile based Applications Market by Country, 2020 - 2023, USD Million
  • TABLE 8 Asia Pacific Mobile based Applications Market by Country, 2024 - 2031, USD Million
  • TABLE 9 Asia Pacific Sensors Market by Country, 2020 - 2023, USD Million
  • TABLE 10 Asia Pacific Sensors Market by Country, 2024 - 2031, USD Million
  • TABLE 11 Asia Pacific Other Type Market by Country, 2020 - 2023, USD Million
  • TABLE 12 Asia Pacific Other Type Market by Country, 2024 - 2031, USD Million
  • TABLE 13 Asia Pacific Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
  • TABLE 14 Asia Pacific Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
  • TABLE 15 Asia Pacific Diagnostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
  • TABLE 16 Asia Pacific Diagnostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
  • TABLE 17 Asia Pacific Monitoring Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
  • TABLE 18 Asia Pacific Monitoring Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
  • TABLE 19 Asia Pacific Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
  • TABLE 20 Asia Pacific Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
  • TABLE 21 Asia Pacific Other Clinical Practice Market by Country, 2020 - 2023, USD Million
  • TABLE 22 Asia Pacific Other Clinical Practice Market by Country, 2024 - 2031, USD Million
  • TABLE 23 Asia Pacific Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
  • TABLE 24 Asia Pacific Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
  • TABLE 25 Asia Pacific Healthcare Companies Market by Country, 2020 - 2023, USD Million
  • TABLE 26 Asia Pacific Healthcare Companies Market by Country, 2024 - 2031, USD Million
  • TABLE 27 Asia Pacific Healthcare Providers Market by Country, 2020 - 2023, USD Million
  • TABLE 28 Asia Pacific Healthcare Providers Market by Country, 2024 - 2031, USD Million
  • TABLE 29 Asia Pacific Payers Market by Country, 2020 - 2023, USD Million
  • TABLE 30 Asia Pacific Payers Market by Country, 2024 - 2031, USD Million
  • TABLE 31 Asia Pacific Other End Use Market by Country, 2020 - 2023, USD Million
  • TABLE 32 Asia Pacific Other End Use Market by Country, 2024 - 2031, USD Million
  • TABLE 33 Asia Pacific Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
  • TABLE 34 Asia Pacific Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
  • TABLE 35 China Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
  • TABLE 36 China Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
  • TABLE 37 China Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
  • TABLE 38 China Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
  • TABLE 39 China Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
  • TABLE 40 China Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
  • TABLE 41 China Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
  • TABLE 42 China Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
  • TABLE 43 Japan Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
  • TABLE 44 Japan Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
  • TABLE 45 Japan Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
  • TABLE 46 Japan Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
  • TABLE 47 Japan Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
  • TABLE 48 Japan Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
  • TABLE 49 Japan Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
  • TABLE 50 Japan Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
  • TABLE 51 India Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
  • TABLE 52 India Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
  • TABLE 53 India Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
  • TABLE 54 India Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
  • TABLE 55 India Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
  • TABLE 56 India Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
  • TABLE 57 India Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
  • TABLE 58 India Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
  • TABLE 59 South Korea Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
  • TABLE 60 South Korea Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
  • TABLE 61 South Korea Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
  • TABLE 62 South Korea Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
  • TABLE 63 South Korea Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
  • TABLE 64 South Korea Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
  • TABLE 65 South Korea Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
  • TABLE 66 South Korea Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
  • TABLE 67 Singapore Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
  • TABLE 68 Singapore Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
  • TABLE 69 Singapore Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
  • TABLE 70 Singapore Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
  • TABLE 71 Singapore Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
  • TABLE 72 Singapore Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
  • TABLE 73 Singapore Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
  • TABLE 74 Singapore Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
  • TABLE 75 Malaysia Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
  • TABLE 76 Malaysia Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
  • TABLE 77 Malaysia Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
  • TABLE 78 Malaysia Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
  • TABLE 79 Malaysia Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
  • TABLE 80 Malaysia Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
  • TABLE 81 Malaysia Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
  • TABLE 82 Malaysia Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
  • TABLE 83 Rest of Asia Pacific Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
  • TABLE 84 Rest of Asia Pacific Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
  • TABLE 85 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
  • TABLE 86 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
  • TABLE 87 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
  • TABLE 88 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
  • TABLE 89 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
  • TABLE 90 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
  • TABLE 91 Key Information - Canary Speech, Inc.
  • TABLE 92 Key Information - Sonde Health, Inc.
  • TABLE 93 Key Information - Koneksa Health Inc.
  • TABLE 94 Key Information - Empatica Inc.
  • TABLE 95 Key Information - VivoSense, Inc.
  • TABLE 96 Key Information - IXICO plc
  • TABLE 97 Key Information - Neurotrack Technologies, Inc.
  • TABLE 98 Key Information - WinterLight Labs
  • TABLE 99 Key Information - Aural Analytics, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!